Related Experiment Video
Updated: Jun 20, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
Bioidentical hormones for maturing women
1Albert Einstein College of Medicine, Montefiore Medical Center, New York, United States. Beldner@aol.com
Many women seek relief from climacteric symptoms using compounded bioidentical hormones due to mistrust of conventional medicine. This review clarifies the term and examines the evidence for their efficacy and safety.
Area of Science:
- Reproductive endocrinology and women's health.
- Pharmacology and drug safety.
- Evidence-based medicine.
Background:
- Climacteric symptoms significantly impact women's quality of life.
- A growing population of baby boomers is experiencing these symptoms.
- Mistrust in traditional medical treatments drives interest in alternative therapies.
Purpose of the Study:
- To define the term "compounded bioidentical hormones."
- To review the available evidence on the efficacy of these hormones.
- To discuss the safety profile and potential risks associated with their use.
Main Methods:
- Literature review of scientific publications.
- Analysis of studies on compounded bioidentical hormone therapy.
- Examination of regulatory and clinical guidelines.
Main Results:
- The term "compounded bioidentical hormones" lacks a precise, universally accepted definition.
- Evidence supporting the efficacy of these treatments for climacteric symptoms is limited and often anecdotal.
- Safety data is scarce, with potential risks not fully elucidated.
Conclusions:
- Compounded bioidentical hormones are increasingly sought by women for symptom relief.
- Further rigorous research is needed to establish clear definitions, efficacy, and safety.
- Healthcare providers should engage in informed discussions regarding these therapies.
Related Concept Videos
Menopause
Major Hormones and Their Functions
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and lactation.
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
Hormonal Control of the Ovarian Cycle
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Hormonal Regulation
Hormonal Regulation